Navigation Links
Biophysical Society announces new and notable symposium speakers
Date:1/25/2008

Bethesda, MD The Biophysical Society has announced the speakers for the New and Notable Symposium at the Joint Meeting of the Biophysical Society and the International Biophysics Congress in Long Beach, California, February 2-6, 2008. The new and notable symposium highlights the latest and most exciting discoveries in biophysics. Speakers are nominated and selected by the Societys program committee. The session will take place Tuesday February 5, 2008 from 4:00-6:00 PM in Ballroom 1 of the Long Beach Convention Center. Registration for the meeting is required.

New and Notable Symposium Speakers and Information:

The Effect of Chaperone SecB on MBP Folding: A Single-molecule Study.
Sander J. Tans, AMOLF institute, Amsterdam, the Netherlands.

Dr. Tans has conducted the first experimental study to show how a chaperone affects a protein folding pathway. The chaperone was shown to interfere specifically with some folding transitions, and to prevent protein aggregation. Laser tweezers combined with MD simulations enabled these single molecule investigations. Studies of folding pathways have so far mainly focused on proteins in isolation. Protein misfolding and aggregation is thought to cause Alzheimers disease, for instance. This work was recently published in Science.

The Kinesin13-microtubule Complex.
Hernando Sosa, Albert Einstein College of Medicine.

Dr. Sosa has recently obtained a 3D map by cryo-electron microscopy and helical reconstruction of the kinesin-13 motor domain interacting with microtubules. The structure is very different from other kinesin-microtubule complexes. It shows the kinesin13 motor domain interacting with a curved protofilament and reveals a new microtubule binding site on the notor domain. This is the first 3D cryo-em map revealing the interaction of the kinesin-13 motor domain with a curved protofilament and provides a snapshot of the depolymerization cycle.

High-resolution Structure of the Human beta2-adrenergic Receptor.
Vadim Cherezov, The Scripps Research Institute.

Dr. Cherezov has solved the first high-resolution structure of a human G protein-coupled receptor with a diffusible ligand. This breakthrough represents the initial step in elucidating structural aspects of the ligand binding specifity and the mechanism of signal transduction by this diverse family of human druggable receptors. This is a major breakthrough that could only have been realized with the conjunction of the in meso method for membrane protein crystallization, a novel synchrotron X-ray beam and a suitably engineered protein. The target protein is of great biological and medical relevance.

Determining the Architectures of Macromolecular Assemblies by Integrating Spatial Restraints from Proteomic Data.
Frank Alber, University of Sounther California.

Dr. Alber has devised an integrative approach to determine the architectures of macromolecular assemblies from diverse biophysical and proteomic data. By applying this approach, he and his colleagues have determined the configuration of the 456 proteins in the nuclear pore complex (NPC) and gained insights into the assembly's evolution and architectural principles. The NPC controls the access of macromolecules in and out of the cell nucleus. The approach can, in principle, be applied to resolve the architectures of many other macromolecular complexes.

For more information or press credentials, contact Ellen Weiss at eweiss@biophysics org, or stop by the Society office located in the Room 103A of the Long Beach convention center.


'/>"/>

Contact: Ellen R. Weiss
eweiss@biophysics.org
301-634-7176
Biophysical Society
Source:Eurekalert

Related biology news :

1. Biophysical Society to host discussions on the teaching of evolution and on the energy crisis
2. Biophysical Society announces winners of 2008 Minority Travel Awards
3. Biophysical Society announces winners of 2008 Student Travel Awards
4. Biophysical Society announces 2008 International Travel Awards
5. Media highlights in the Dec. 15 issue of Biophysical Journal
6. Roger Kornberg to present lecture at the Joint Biophysical Society/IUPAB Meeting
7. Media highlights in the November issues of Biophysical Journal
8. American Chemical Societys Weekly PressPac -- Jan. 16, 2008
9. American Chemical Societys weekly PressPac -- Jan. 9, 2008
10. American Chemical Societys weekly PressPac -- Jan. 2, 2008
11. American Chemical Societys Weekly PressPac -- Dec. 19, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist ... as its new chief executive officer (CEO). Freischlag joins ... John D. McConnell , M.D., who last year ... at the Medical Center, after leading it since 2008. ... full scope of Wake Forest Baptist,s academic health system, ...
(Date:2/10/2017)... Research and Markets has announced ... - Scientific and Commercial Aspects" to their offering. ... Biomarkers ... with therapy for selection of treatment as well for monitoring ... of disease in modern medicine. Biochip/microarray technologies and next generation ...
(Date:2/8/2017)... BEDFORD, Mass., Feb. 7, 2017  Aware, Inc. (NASDAQ: ... services, today reported financial results for its quarter and year ... fourth quarter of 2016 was $3.9 million compared to $6.9 ... the fourth quarter of 2016 was $0.6 million compared to ... in the fourth quarter of 2016 was $0.5 million, or ...
Breaking Biology News(10 mins):
(Date:3/1/2017)... ... March 01, 2017 , ... Ace Laboratories, ... into clinical applications, announces the formation of its Scientific and Clinical Advisory Board. ... the drug which has been discussed in the media as “the red wine ...
(Date:2/28/2017)... ... , ... Surface Plasmon Resonance (SPR) is a widely-used, label-free technique to characterize ... changes in the dielectric properties of the medium close to a metal surface. ... to 300 nm above the metal surface (Au) and thus by the material absorbed ...
(Date:2/28/2017)... NEW YORK , Feb. 28, 2017 /PRNewswire/ ... company, announced today the formation of the Phosphorus ... and science experts chosen to advise the company ... company,s large-scale, multi-site research initiatives. Please visit ... team and initiatives. "We,ve gathered some ...
(Date:2/28/2017)... -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing ... diseases, asthma and allergic diseases and cancer, today ... full year ended December 31, 2016 and provided ... clinical highlights. "During 2016, we made ... starting five clinical trials across our XmAb portfolio.  ...
Breaking Biology Technology: